PJ009

DRUG2 trials

Sponsors

Chongqing Peg-Bio Biopharm Co., Ltd.

Conditions

Short Bowel Syndrome

Phase 1

A Study of PJ009 in Healthy Adult Volunteers

CompletedNCT06523101

Chongqing Peg-Bio Biopharm Co., Ltd.Short Bowel Syndrome

Start: 2023-02-28End: 2023-05-15Updated: 2024-07-29

Phase 3

Efficacy and Safety of PJ009 in Patients With Short Bowel Syndrome Requiring Parenteral Nutrition

RecruitingNCT06512584

Chongqing Peg-Bio Biopharm Co., Ltd.Short Bowel Syndrome

Start: 2024-09-03End: 2026-04-27Target: 72Updated: 2026-03-02